{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:28:15Z","timestamp":1761514095290},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T00:00:00Z","timestamp":1509753600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The National Key Research and Development Program of China, National Key Research and Development Program of China","award":["National Key Research and Development Program of China"],"award-info":[{"award-number":["National Key Research and Development Program of China"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC0800701"],"award-info":[{"award-number":["2016YFC0800701"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Fundamental Research Funds for the Central Universities, HUST","award":["No. 2016JCTD117"],"award-info":[{"award-number":["No. 2016JCTD117"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Sci Med Pathol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12024-017-9925-y","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T00:50:29Z","timestamp":1509756629000},"page":"444-449","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sudden death due to malignant hyperthermia with a mutation of RYR1: autopsy, morphology and genetic analysis"],"prefix":"10.1007","volume":"13","author":[{"given":"Wenhe","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,4]]},"reference":[{"key":"9925_CR1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","volume":"34","author":"MA Denborough","year":"1962","unstructured":"Denborough MA, Forster JF, Lovell RR, Maplestone PA, Villiers JD. Anaesthetic deaths in a family. Br J Anaesth. 1962;34:395.","journal-title":"Br J Anaesth"},{"key":"9925_CR2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1213\/ANE.0000000000000421","volume":"119","author":"MG Larach","year":"2014","unstructured":"Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesth Analg. 2014;119:1359\u201366.","journal-title":"Anesth Analg"},{"key":"9925_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/humu.1203","volume":"18","author":"T Girard","year":"2001","unstructured":"Girard T, Urwyler A, Censier K, Mueller CR, Zorzato F, Treves S. Genotype-phenotype comparison of the Swiss malignant hyperthermia population. Hum Mutat. 2001;18:357\u20138.","journal-title":"Hum Mutat"},{"key":"9925_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0379-0738(02)00272-4","volume":"129","author":"B Karger","year":"2002","unstructured":"Karger B, Teige K. Fatal malignant hyperthermia\u2014delayed onset and atypical course. Forensic Sci Int. 2002;129:187\u201390.","journal-title":"Forensic Sci Int"},{"key":"9925_CR5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.legalmed.2008.12.004","volume":"11","author":"H Nishio","year":"2009","unstructured":"Nishio H, Sato T, Fukunishi S, Tamura A, Iwata M, Tsuboi K, et al. Identification of malignant hyperthermia-susceptible ryanodine receptor type 1 gene (RYR1) mutations in a child who died in a car after exposure to a high environmental temperature. Legal Med. 2009;11:142\u20133.","journal-title":"Legal Med"},{"key":"9925_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1399-6576.2011.02573.x","volume":"56","author":"T Migita","year":"2012","unstructured":"Migita T, Mukaida K, Kobayashi M, Hamada H, Kawamoto M. The severity of sevoflurane-induced malignant hyperthermia. Acta Anaesthesiol Scand. 2012;56:351\u20136.","journal-title":"Acta Anaesthesiol Scand"},{"key":"9925_CR7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/oxfordjournals.bja.a013478","volume":"84","author":"D Chamley","year":"2000","unstructured":"Chamley D, Pollock NA, Stowell KM, Brown RL. Malignant hyperthermia in infancy and identification of novel RYR1 mutation. Br J Anaesth. 2000;84:500\u20134.","journal-title":"Br J Anaesth"},{"key":"9925_CR8","first-page":"369","volume":"45","author":"JE Heggie","year":"2002","unstructured":"Heggie JE. Malignant hyperthermia: considerations for the general surgeon. Can J Surg. 2002;45:369.","journal-title":"Can J Surg"},{"key":"9925_CR9","doi-asserted-by":"crossref","first-page":"9310","DOI":"10.1016\/S0021-9258(19)76541-7","volume":"263","author":"JR Mickelson","year":"1988","unstructured":"Mickelson JR, Gallant EM, Litterer LA, Johnson KM, Rempel WE, Louis CF. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem. 1988;263:9310\u20135.","journal-title":"J Biol Chem"},{"key":"9925_CR10","doi-asserted-by":"publisher","unstructured":"Schuster F, Johannsen S, Roewer N, et al. A minimal-invasive metabolic test detects malignant hyperthermia susceptibility in a patient after sevoflurane-induced metabolic crisis. Case Rep Anesthesiol 2013;872310. https:\/\/doi.org\/10.1155\/2013\/953859 .","DOI":"10.1155\/2013\/953859"},{"key":"9925_CR11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0006-3495(90)82563-7","volume":"57","author":"M Fill","year":"1990","unstructured":"Fill M, Coronado R, Mickelson JR, Vilven J, Ma JJ, Jacobson BA, et al. Abnormal ryanodine receptor channels in malignant hyperthermia. Biophys J. 1990;57:471\u20135.","journal-title":"Biophys J"},{"key":"9925_CR12","first-page":"84","volume":"23","author":"H Rosenberg","year":"1994","unstructured":"Rosenberg H, Fletcher J. An update on the malignant hyperthermia syndrome. Ann Acad Med Singap. 1994;23:84\u201397.","journal-title":"Ann Acad Med Singap"},{"key":"9925_CR13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","volume":"23","author":"K Jurkat-Rott","year":"2000","unstructured":"Jurkat-Rott K, McCarthy T, Lehmann-Horn F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve. 2000;23:4\u201317.","journal-title":"Muscle Nerve"},{"key":"9925_CR14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause T, Gerbershagen M, Fiege M, Weisshorn R, Wappler F. Dantrolene\u2013a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004;59:364\u201373.","journal-title":"Anaesthesia"},{"key":"9925_CR15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.paf.0000137345.49901.93","volume":"25","author":"LR Christiansen","year":"2004","unstructured":"Christiansen LR, Collins KA. Pathologic findings in malignant hyperthermia: a case report and review of literature. Am J Forensic Med Pathol. 2004;25:327\u201333.","journal-title":"Am J Forensic Med Pathol"},{"key":"9925_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/bja\/79.3.327","volume":"79","author":"P Mezin","year":"1997","unstructured":"Mezin P, Payen J, Bosson J, Brambilla E, Stieglitz P. Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies. Br J Anaesth. 1997;79:327\u201331.","journal-title":"Br J Anaesth"},{"key":"9925_CR17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","volume":"110","author":"MG Larach","year":"2010","unstructured":"Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010;110:498\u2013507.","journal-title":"Anesth Analg"},{"key":"9925_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00414-012-0722-6","volume":"127","author":"C Palmiere","year":"2013","unstructured":"Palmiere C, Mangin P. Hyperthermia and postmortem biochemical investigations. Int J Legal Med. 2013;127:93\u2013102.","journal-title":"Int J Legal Med"},{"key":"9925_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jcp.45.4.361","volume":"45","author":"R Prescott","year":"1992","unstructured":"Prescott R, Roberts S, Williams G. Malignant hyperpyrexia: a rare cause of postoperative death. J Clin Pathol. 1992;45:361\u20133.","journal-title":"J Clin Pathol"},{"key":"9925_CR20","first-page":"51","volume":"89","author":"J Fenoglio Jr","year":"1977","unstructured":"Fenoglio J Jr, Irey N. Myocardial changes in malignant hyperthermia. Am J Pathol. 1977;89:51.","journal-title":"Am J Pathol"},{"key":"9925_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jmg.35.3.196","volume":"35","author":"R Robinson","year":"1998","unstructured":"Robinson R, Curran J, Hall W, Halsall P, Hopkins P, Markham A, et al. Genetic heterogeneity and HOMOG analysis in British malignant hyperthermia families. J Med Genet. 1998;35:196\u2013201.","journal-title":"J Med Genet"},{"key":"9925_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/geno.1996.0238","volume":"34","author":"MS Phillips","year":"1996","unstructured":"Phillips MS, Fujii J, Khanna VK, DeLeon S, Yokobata K, de Jong PJ, et al. The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics. 1996;34:24\u201341.","journal-title":"Genomics"},{"key":"9925_CR23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/humu.10098","volume":"20","author":"RL Robinson","year":"2002","unstructured":"Robinson RL, Brooks C, Brown SL, Ellis FR, Halsall PJ, Quinnell RJ, et al. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Hum Mutat. 2002;20:88\u201397.","journal-title":"Hum Mutat"},{"key":"9925_CR24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/geno.1994.1483","volume":"23","author":"KA Quane","year":"1994","unstructured":"Quane KA, Keating KE, Healy JS, Manning BM, Krivosic-Horber R, Krivosic I, et al. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores. Genomics. 1994;23:236\u20139.","journal-title":"Genomics"},{"key":"9925_CR25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1399-0004.1996.tb03284.x","volume":"49","author":"T Fagerlund","year":"1996","unstructured":"Fagerlund T, Ording H, Bendixen D, et al. RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibility. Clin Genet. 1996;49:186.","journal-title":"Clin Genet"},{"key":"9925_CR26","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1001\/jama.293.23.2918","volume":"293","author":"RS Litman","year":"2005","unstructured":"Litman RS, Rosenberg H. Malignant hyperthermia: update on susceptibility testing. JAMA. 2005;293:2918\u201324.","journal-title":"JAMA"},{"key":"9925_CR27","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1100\/tsw.2006.289","volume":"6","author":"BW Brandom","year":"2006","unstructured":"Brandom BW. Genetics of malignant hyperthermia. Sci World J. 2006;6:1722\u201330.","journal-title":"Sci World J"},{"key":"9925_CR28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajmg.10011","volume":"106","author":"W Burke","year":"2001","unstructured":"Burke W, Pinsky LE, Press NA. Categorizing genetic tests to identify their ethical, legal, and social implications. Am J Med Genet. 2001;106:233\u201340.","journal-title":"Am J Med Genet"},{"key":"9925_CR29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1213\/ANE.0000000000000063","volume":"118","author":"KM Stowell","year":"2014","unstructured":"Stowell KM. DNA testing for malignant hyperthermia: the reality and the dream. Anesth Analg. 2014;118:397\u2013406.","journal-title":"Anesth Analg"},{"key":"9925_CR30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","volume":"10","author":"H Rosenberg","year":"2015","unstructured":"Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015;10:93.","journal-title":"Orphanet J Rare Dis"},{"key":"9925_CR31","doi-asserted-by":"crossref","unstructured":"Rosenberg H, Rueffert H. Clinical utility gene card for: malignant hyperthermia. Eur J Hum Genet. 2011;19:6.","DOI":"10.1038\/ejhg.2010.248"},{"key":"9925_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis. 2007;2:21.","journal-title":"Orphanet J Rare Dis"},{"key":"9925_CR33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2146\/ajhp110543","volume":"70","author":"ME Musselman","year":"2013","unstructured":"Musselman ME, Saely S. Diagnosis and treatment of drug-induced hyperthermia. Am J Health Syst Pharm. 2013;70:34\u201342.","journal-title":"Am J Health Syst Pharm"},{"key":"9925_CR34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/bja\/aeq243","volume":"105","author":"KPE Glahn","year":"2010","unstructured":"Glahn KPE, Ellis FR, Halsall PJ, M\u00fcller CR, Snoeck MMJ, Urwyler A, et al. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth. 2010;105:417\u201320.","journal-title":"Br J Anaesth"}],"container-title":["Forensic Science, Medicine and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12024-017-9925-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-017-9925-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-017-9925-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T10:55:35Z","timestamp":1659783335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12024-017-9925-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["9925"],"URL":"https:\/\/doi.org\/10.1007\/s12024-017-9925-y","relation":{},"ISSN":["1547-769X","1556-2891"],"issn-type":[{"value":"1547-769X","type":"print"},{"value":"1556-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,4]]}}}